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Introduction
DCs in the immune system are well characterized as potent antigen-
presenting cells (APCs) for driving T cell–mediated host defense. 
Much of this activity takes place in lymph nodes (LNs), specialized 
filters of the immune system that are interspersed along lymphatic 
vessels that carry fluid, macromolecules, and recirculating cells 
from tissue interstitial space, with eventual return of the filtrate to 
the blood (1). Indeed, lymph is the major source of antigen supply to 
LNs, arriving either within migratory DCs traveling through lymph 
(1) or as free antigen available for capture by resident DCs already 
in LNs (2). Beyond antigen presentation, migratory DCs have been 
identified as critical players in governing functional homeostasis of 
the LN itself, acting to promote appropriate differentiation of high 
endothelial venules (HEVs) (3) and survival of stromal cells in the 
LNs (4). For any of these tasks, these cells travel to the LNs using 
the canonical G protein–coupled homing receptor CCR7. CCR7 is 
crucial to DC and T cell homing to LNs (5) and participates in the 
entry of DCs into lymphatic capillaries within peripheral organs 
such as skin and separately regulates the passage of LN-resident 
DC subsets across HEVs (6). The CCR7-dependent migration of 
DCs through the afferent lymphatic vasculature, however, domi-
nates in its importance to the establishment of mature, functional 
LNs. That is, if DCs fail to traverse the lymphatic capillary vascula-
ture due to the lack of CCR7, the LNs does not acquire the appropri-
ate characteristics to recruit T cells (7).
A major ligand for CCR7 is CCL21, constitutively expressed by 
lymphatic capillary endothelium and bound in a haptotactic gra-
dient to aid in the guidance of DCs to the blind-ended lymphatic 
termini (8), where DCs enter through holes in the basement mem-
brane and partially open flaps in the lymphatic vessel (9) with-
out requirement for integrins to directly interact with lymphatic 
endothelium (10). Whether a DC perceives the CCL21 gradient is 
largely a function of whether it has matured sufficiently to express 
an appropriate amount of CCR7.
Although DCs appear to exclusively access the lymphatic sys-
tem along the capillary portion of the lymphatic vasculature (9), 
close to lymphatic termini, the functional units of the lymphatic 
vasculature that ultimately control lymph flow are the larger 
lymphatic trunks, or lymphatic collecting vessels, that are down-
stream of lymphatic capillaries and receive input from them (1). 
Lymphatic collecting vessels possess intrinsic pumping activ-
ity that creates and sustains flow of lymph through the lymphatic 
system (11, 12) and, by extension, flow of interstitial fluid through 
interstitial spaces between cells in all organs (1).
Lymphatic collecting vessels are housed in adipose tissue 
around LNs. We have recently shown that DCs and macrophages 
that reside in this adipose tissue continuously sample lymph that, 
due to the basal permeability of lymphatic collecting vessels (13), 
leaks out into the surrounding perinodal adipose tissue (14). Only 
Lymphatic collecting vessels direct lymph into and from lymph nodes (LNs) and can become hyperpermeable as the result of 
a previous infection. Enhanced permeability has been implicated in compromised immunity due to reduced flow of lymph and 
immune cells to LNs, which are the primary site of antigen presentation to T cells. Presently, very little is known about the 
molecular signals that affect lymphatic collecting vessel permeability. Here, we have shown that lymphatic collecting vessel 
permeability is controlled by CCR7 and that the chronic hyperpermeability of collecting vessels observed in Ccr7–/– mice is 
followed by vessel fibrosis. Reexpression of CCR7 in DCs, however, was sufficient to reverse the development of such fibrosis. 
IFN regulatory factor 4–positive (IRF4+) DCs constitutively interacted with collecting lymphatics, and selective ablation of this 
DC subset in Cd11c-Cre Irf4fl/fl mice also rendered lymphatic collecting vessels hyperpermeable and fibrotic. Together, our data 
reveal that CCR7 plays multifaceted roles in regulating collecting vessel permeability and fibrosis, with one of the key players 
being IRF4-dependent DCs.
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major sites of immune cell entry. Yet we observe that lymphatic 
collecting vessels constitutively displayed CCL21 (ref. 14 and Fig-
ure 1A). As DCs had also been observed to interact with collecting 
vessels (14), we wondered whether their interaction with the lym-
phatic collecting vessel might involve the CCL21 ligand CCR7. We 
thus crossed Cd11c-YFP (where YFP indicates yellow fluorescent 
protein) transgenic mice (16), in which intense YFP expression in 
perinodal adipose tissue marks DCs but not macrophages (14), 
with Ccr7–/– and Ccr7+/+ mice to study this question. In some exper-
iments, the progeny from this cross were further bred with Prox1-
ERT2-Cre (17) × Tomato reporter mice so that lymphatic vessels 
were constitutively fluorescent. YFP+ DCs visualized in Ccr7+/+ 
or Ccr7+/– mice intimately interacted with lymphatic collecting 
vessels, as has been previously published (14), and remained 
durably associated with them (Supplemental Videos 1–3; supple-
mental material available online with this article; doi:10.1172/
JCI84518DS1). Cytoplasmic extensions from DCs were observed 
to cross the lymphatic collecting vessel wall toward the lumen 
(Supplemental Video 1, Ccr7+/+ analysis on left). DC motility 
around the vessel, and throughout the adipose tissue, remained 
high even when the lumen was not filled with tracers injected in 
the skin, but was instead made visible by Prox1-driven Tomato 
expression (Supplemental Video 2). DC activity was observed 
throughout the vessel area, including around valves (Supplemen-
tal Video 3). In contrast, YFP+ DCs visualized in the Ccr7–/– back-
under exceptional circumstances do these lymphatic-associated, 
adipose tissue DCs mobilize to LNs (14), so the reason why they con-
stitutively interact with the lymphatic collecting vessel and monitor 
the filtrate from this vessel has been unclear. Recently, extremely 
permeable lymphatic collecting vessels were identified as a conse-
quence of aberrant healing following infection with Yersinia pestis 
(15). These collecting vessels became leaky enough to prevent the 
arrival of migratory DCs in draining mesenteric LNs. Consequently, 
immune protection was defective. The mechanisms accounting for 
the high permeability in lymphatic collecting vessels following Y. 
pestis infection remain unclear. Indeed, very little is known about 
how lymphatic permeability is regulated under any circumstance.
Here, we reveal a role for CCR7 in controlling lymphatic col-
lecting vessel permeability. CCR7 deficiency leads to greatly 
increased basal permeability of lymphatic collecting vessels. 
At least part of the role of CCR7 in controlling this permeability 
relates to a role for DCs. In particular, the subset of DCs that inti-
mately interacts with collecting vessels, IFN regulatory factor 4–
dependent (IRF4-dependent) CD11b+ DCs, is implicated in the 
control of lymphatic permeability.
Results
Ccr7–/– mice exhibit fibrotic lymphatic collecting vessels and disrupted 
interactions with DCs. In contrast with lymphatic capillaries, lym-
phatic collecting vessels have not been observed as functioning as 
Figure 1. CCR7-mediated interactions of DCs with lymphat-
ic collecting vessels outside of LNs. (A) Whole-mount prep-
aration of brachial adipose tissue containing the brachial 
LNs with CCL21 staining shown in white. DyLight 594–conju-
gated lectin (red) was injected s.c. to visualize the draining 
lymphatic vasculature, and DyLight 488–conjugated lectin 
was i.v. administered in order to map the blood vasculature. 
White inset is placed around the major lymphatic collecting 
vessel afferent to the brachial LNs and shown at greater 
magnification on the right. (B) Contact area between DCs 
and lymphatic collecting vessels in Cd11c-YFP Ccr7+/+ and 
Cd11c-YFP Ccr7–/– mice was quantified from single videos 
prepared during 2-photon intravital imaging, as described in 
Methods (see also Supplemental Video 2). Each data point 
represents analysis of 1 Z-stack, with 5 to 7 Z-stacks exam-
ined per mouse. Other measurements assessed from these 
videos were mean DC velocity (C), meandering index (D), and 
motility coefficient (E). From 4 to 5 mice per genotype were 
examined, with multiple areas along the lymphatic collect-
ing vessel analyzed per mouse. For C–E, each data point 
represents tracking from an individual cell, with 7 to 10 cells 
tracked from 4 to 5 mice per genotype. In C–E, each mouse 
is plotted using a distinct symbol shape. Mann-Whitney U 
tests were performed for assessment of statistical signifi-
cance. **P < 0.01; ***P < 0.001.
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not recapitulated in Rag2–/– mice lacking lymphocytes (Figure 2B), 
suggesting that adventitial wall thickening was not driven by a loss 
of lymphocyte interactions. This was an important issue since, 
besides DCs, lymphocytes depend upon CCR7 for trafficking. 
We also tested to determine whether other chemokine receptors 
on DCs gave rise to similar outcomes. DCs around lymphatic col-
lecting vessels are from the CD11b+ subset of DCs (14) and express 
GFP in Cx3cr1gfp/+ mice (Supplemental Figure 1), similarly to some 
other CD11b+ DCs (18). However, loss of CX3CR1 expression did 
not affect accumulation of the second harmonic signal in the lym-
phatic adventitia (Figure 2B).
Second harmonic signal in 2-photon microscopy is typically con-
sidered as deriving from accumulated collagen. To verify that such 
signal indeed corresponded to increased collagen in the adventitia 
of lymphatic collecting vessels from Ccr7–/– mice, transmission elec-
tron microscopy of lymphatic collecting vessels in Ccr7+/+ and Ccr7–/– 
perinodal adipose tissue was carried out. Ccr7–/– lymphatic collect-
ing vessels displayed uneven masses of collagen fibrils outside of 
the vessels, which was especially evident at lower magnification 
(Figure 3, A and C). Fibroblasts were also observed within the excess 
adventitial collagen observed in Ccr7–/– mice (Figure 3, compare A to 
C, B to D). At higher magnification, individual collagen fibrils were 
discernible (Figure 3, E and F). These fibrils were denser and had a 
distinct appearance in Ccr7–/– collecting lymphatics (Figure 3, E and 
F). This analysis confirms that the increased second harmonic gen-
eration quantified in Ccr7–/– mice compared with Ccr7+/+ mice (Fig-
ure 2) relates to an accumulation of extracellular matrix around the 
Ccr7–/– vessels. Overall, the data indicate lymphatic collecting vessel 
fibrosis occurs progressively in mice lacking CCR7.
ground only briefly interacted or failed to interact with collecting 
vessels (Supplemental Video 1, Ccr7–/– analysis on the right). We 
thus developed a method using MATLAB to quantify the surface 
of lymphatic vessels that were in contact with DCs (Supplemental 
Video 4) in the 2 genotypes. This analysis indicated an approxi-
mate 5-fold reduction in DC contact with collecting lymphat-
ics in the Ccr7–/– background (Figure 1B). Mean track velocity of 
DCs in Ccr7–/– mice was not significantly different than in Ccr7+/+ 
mice (Figure 1C). However, the meandering index, which assesses 
straightness of the migration path (a straight path is low mean-
dering) and the aggregated motility coefficient, which assesses 
the net distance traveled from the point of origin, were higher in 
CD11c-YFP+ DCs lacking CCR7 (Figure 1, D and E). Thus, in adult 
mice, absence of CCR7 expression impairs DC interaction with 
lymphatic collecting vessels in perinodal adipose tissue.
Examination of these videos, and analysis of individual 
Z-stacks from them, revealed not only reduced interaction of DCs 
with lymphatic collecting vessels in Ccr7–/– mice, but also that the 
vessels possessed an increased second harmonic signal on the 
outside at the adventitial interface (Figure 2A; compare second 
harmonic wall diameter in the 2 videos included in Supplemental 
Video 1). We quantified the lymphatic adventitial diameter (thick-
ness of region along the outer margins of the vessels correspond-
ing to second harmonic signal) (Figure 2B). Collecting vessels in 
Ccr7–/– mice displayed no differences from those of controls in the 
adventitial wall thickness at 5 weeks of age, but increased adven-
titial wall thickening was apparent by 7 to 9 weeks of age in Ccr7–/– 
mice that was even more marked at 10 to 12 weeks of age (Figure 
2B). Thickening of the lymphatic collecting adventitial wall was 
Figure 2. Increased adventitial wall thickness in lym-
phatic collecting vessels of Ccr7–/– mice. (A) Images, 
each a single Z-plane, of the lymphatic collecting 
vessel afferent to the popliteal LNs in Ccr7+/– (left) or 
Ccr7–/– (2 images on right) mice. White arrows point 
to the second harmonic signal. Scale bars: 50 μm. 
Image from Ccr7–/– mouse in the middle is representa-
tive of the average difference compared with control 
mice; image on the far right displays the occasional 
regions of extreme fibrosis observed. (B) 2-Photon 
intravital analysis of the lymphatic collector vessel 
adventitial wall thickness in multiple strains of mice. 
From 3 to 6 mice per genotype were examined at 
multiple areas along the lymphatic collecting vessel 
analyzed per mouse. Each data point represents the 
mean result from 1 mouse after analysis of randomly 
selected time points from 2-photon images with 3 to 
5 Z-stacks examined per mouse. For statistical evalu-
ation, 1-way ANOVA with Tukey’s post hoc test was 
carried out. *P < 0.05; **P < 0.01.
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to the change in permeability and (b) that, given the robust inter-
action we observed between collecting vessels and DCs (Figure 1 
and ref. 14), the role of CCR7 in controlling permeability involves 
a requirement for DCs in regulating lymphatic permeability. Sup-
port for the first hypothesis was obtained by the demonstration 
that, whereas fibrosis is a progressive phenotype in Ccr7–/– mice not 
observed until 8 weeks of age, we found that the permeability was 
pervasively elevated, that is, we were able to cannulate lymphatic 
collecting vessels from mice as young as 5 weeks of age, and their 
permeability was elevated in these young mice similarly to the way 
it was in the older mice (Figure 4C). Therefore, hyperpermeability 
occurs prior to the fibrosis and is not a consequence of it. Other 
reports support the concept that fibrosis may be a consequence 
of increased flow across endothelium that would be induced by 
hyperpermeability (21, 22).
In support of the second hypothesis that DCs may use CCR7 to 
control permeability, we employed conditionally proficient Ccr7 
gene–targeted mice in which the human CCR7 gene is knocked 
into the mouse Ccr7 locus, but is unable to be transcribed due to 
the presence of loxP sites flanking a neo insertion sequence (7). 
This mouse has been referred to as Ccr7–/– CCR7stop/stop. Conditional 
expression of CCR7 is possible in this strain when it is crossed with 
a strain in which Cre recombinase drives the removal of the neo 
cassette and thus expression of human CCR7 (7). Use of a Cd4-Cre 
driver restores CCR7 in CD4+ and CD8+ T cells (T-Ccr7+/+ mice), 
and CD11c-Cre driver restores CCR7 in DCs (DC-Ccr7+/+ mice) (7). 
Analysis of fibrosis in Ccr7–/– CCR7stop/stop mice recapitulated that 
observed in Ccr7–/– mice, where the second harmonic signal was 
elevated around collecting lymphatics (Figure 4D). Remarkably, 
Ccr7–/– mice exhibit hyperpermeable lymphatic collecting ves-
sels and loss of lymphatic transport from the periphery. Adding to 
the known impact of CCR7 deficiency on LN organization (7), 
the findings above suggested that lymphatic vessels supplying 
LNs also depend upon CCR7 to remain normal. We thus evalu-
ated whether the clearance of tracer dye injected into ear skin, 
removed through a lymphatic vessel–dependent process (19), was 
altered in Ccr7–/– mice compared with Ccr7+/+ control mice. Indeed, 
clearance of Cy5-dextran from the ear was reduced by half in 
Ccr7–/– mice (Figure 4A), indicating that lymphatic transport dys-
function was present in Ccr7–/– mice. Because transport into lymph 
is ultimately regulated by the functionality of the downstream 
lymphatic collecting vessel (11, 12), we next evaluated functional 
properties of lymphatic collecting vessels in Ccr7–/– mice. To this 
end, mouse lymphatic collecting vessels afferent to the popliteal 
LNs were exteriorized and investigated ex vivo (20). This proce-
dure removes external adipocytes, but past studies have shown 
that DCs associated with the collecting vessels remain associated 
with them during such preparation (14). Lymphatic contractile 
function over a range of pressures was unaffected (Supplemental 
Figure 2). However, the permeability of lymphatic collecting ves-
sels was markedly enhanced in Ccr7–/– lymphatic collecting vessels 
compared with age-matched WT vessels from mice at 8 weeks or 
older (Figure 4B). Thus, we conclude that lymphatic collecting 
vessel permeability is regulated by CCR7.
Given the observation that permeability of lymphatic col-
lecting vessels was markedly increased in Ccr7–/– mice, we next 
hypothesized that (a) other changes in lymphatic collecting ves-
sels observed in Ccr7–/– mice, notably fibrosis, might be secondary 
Figure 3. Electron micrographs of lymphatic collecting vessels within afferent s.c. adipose tissue near the brachial LNs from Ccr7+/+ or Ccr7–/– mice. 
Lymphatic collecting vessels afferent to the brachial LNs of 12-week-old Ccr7+/+ (A, B, and E) or Ccr7–/– (C, D, and F) mice were examined by transmission 
electron microscopy. Lumens of the collecting vessels are marked with asterisks, and representative fibroblasts (portions of their long and thin cytoplas-
mic projections), adipocytes, and mast cells (MC) are also labeled. Lymphatic endothelial cells are not labeled, but correspond with the cell type nearest 
the lumen marked with an asterisk. Matrix accumulation along the ablumenal or adventitial surface of the endothelium is relatively scarce in Ccr7+/+ 
samples (A and B), but far more evident in Ccr7–/– tissues (C and D). In C, this matrix is observed between the lymphatic lumen and the adipocyte in the 
lower surface of the panel. In D, the field of extracellular matrix occupies the vast majority of the image. In E and F, representative fibrils of collagen are 
labeled with arrowheads. Scale bars: 10 microns (A and C); 5 microns (B and D); 1 micron (E and F). Six mice per genotype were examined over the course of 
2 independent experiments.
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are the most populous DC subset in LNs, accounting for well over 
50% of all LN DCs (27), and therefore we were able to investigate 
whether widespread LN DC depletion prior to lymphatic collect-
ing vessel isolation was able to alter permeability. DT treatment 
in BDCA2-DTR mice gave rise to results consistent with those of 
WT mice without treatment (Figure 5A, compared with Figure 
4, B and C). However, when conventional DCs were depleted in 
Cd11c-DTR mice 36 hours after administering DT and then lym-
phatic collecting vessels were isolated for ex vivo studies, perme-
ability was increased more than 4-fold (Figure 5A). This result is 
consistent with the possibility that DCs acutely regulate lymphatic 
collecting vessel permeability. We also determined whether acute 
depletion of DCs using DT treatment in Cd11c-DTR mice led to 
a reduction in lymphatic transport of dyes injected into the ear 
pinnae. In this assay, we found no differences between mice with 
or without DCs (Figure 5B), indicating that the loss of lymphatic 
transport from the ear and increased permeability of collecting 
vessels were separable processes.
However, while the use of a DT-based system to study 
DC function is helpful, caveats are numerous (28). We thus 
searched for additional approaches to examine the impor-
tance of DCs more selectively. The transcription factor IRF4 
has been linked to the presence of the CD11b+ subset of DCs in 
some tissues (29, 30). Given that DCs in perinodal adipose tis-
sue are mainly of the CD11b+ subset (14) and that those express-
ing CX3CR1 are CD11b+ and located around collecting vessels 
(Supplemental Figure 1), we examined whether perinodal adi-
pose tissue CD11b+ DCs were deleted in Irf4–/– mice or Cd11c-
Cre Irf4fl/fl mice. First, whole-mount immunostaining of peri-
nodal adipose tissue around the brachial LNs revealed a partial 
reduction in local MHC II+ cells in total body Irf4–/– mice com-
conditional expression of CCR7 that was limited to DCs (CD11c+) 
was sufficient to prevent fibrosis in the collecting lymphatic vascu-
lature (Figure 4D). Furthermore, there was a trend in the data sug-
gesting that T cell reexpression of CCR7 was also able to reverse 
fibrosis, although this fell short of reaching statistical significance 
in our analysis. In relation to our hypothesis that CCR7-competent 
DCs prevent fibrosis, these data indicate that the expression of 
CCR7 by DCs indeed prevents fibrosis, but because T cells may be 
capable of preventing fibrosis as well if they are allowed to appro-
priately express CCR7, these data are best interpreted as showing 
that CCR7+ DCs are sufficient for preventing fibrosis, but it is less 
clear here if the DCs are necessary. One additional caveat in this 
scenario might be that some DCs express CD4 (23), while some 
CD8+ T cells express CD11c (24).
Lymphatic collecting vessel permeability is controlled by IRF4-
dependent DCs. Based on the findings above, we set out to further 
evaluate the role of DCs in controlling lymphatic vessel hyperper-
meability and temporally downstream fibrosis. To assess whether 
the increased permeability of the lymphatic collecting vessels iso-
lated from Ccr7–/– mice might be due to loss of DC interaction with 
the vessel, we depleted DCs in Cd11c-DTR transgenic mice (25) 
using diphtheria toxin (DT) in an attempt to disprove the hypoth-
esis that DCs were regulators of permeability. As expected from 
previous studies (25), 1 dose of DT in Cd11c-DTR mice completely 
depleted perinodal adipose DCs for at least 36 hours (Supplemen-
tal Figure 3). We carried out DT-mediated depletion in Cd11c-DTR 
mice and compared them with DT-treated BDCA2-DTR mice as 
a DT treatment and depletion control to remove a different sub-
set of DCs, the plasmacytoid DCs (26). The use of DT in BDCA2-
DTR mice allowed us to test whether DT-mediated killing led to 
nonspecific effects that affected permeability. Plasmacytoid DCs 
Figure 4. Lymphatic transport and permeability in CCR7-
deficient mouse strains. (A) 1 μl of Cy5-conjugated dextran 
(70 kDa) was injected in the ear pinnae of anesthetized 
mice (5 to 10 weeks old), and the decrease of fluorescence 
intensity associated with its transport from the initial site 
of deposition was assessed using a fluorescence stereo-
scope (n = 12 WT, 7 Ccr7–/– mice, mean ± SEM). (B) Measure-
ment of lymphatic collecting vessel permeability from mes-
enteric and popliteal adipose tissue in WT and Ccr7–/– mice 
(n = 5 WT and 8 Ccr7–/– mice combined from 2 independent 
experiments with mice at 10 to 12 weeks of age, mean ± 
SEM). (C) Measurement of the lymphatic collecting vessel 
permeability in 5-week-old WT and Ccr7–/– mice (n = 5 WT 
and 7 Ccr7–/– mice, mean ± SEM). (D) 2-Photon intravital 
analysis of adventitial wall thickness, assessed through 
measurement of second harmonic signal, around lymphatic 
collecting vessels in mice in which the human CCR7 gene 
has been used to disrupt the mouse Ccr7 locus (CCR7stop/stop) 
or mice in which human CCR7 is expressed selectively on 
CD4+ T cells (T-Ccr7+/+) or CD11c+ DCs (DC-Ccr7+/+). In control 
mice, the Ccr7 gene is not disrupted (Total-Ccr7–/–). Six mice 
per genotype were examined at multiple areas along the 
lymphatic collecting vessels. Each data point represents 
the mean wall thickness of 1 mouse after blind scoring of 9 
Z-stacks per mouse. For statistical evaluation, data in A–C 
were assessed using the Mann-Whitney U test and data in 
D employed 1-way ANOVA test, with Tukey’s post hoc test. 
*P < 0.05; **P < 0.01.
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pared with control mice, with many remaining MHC II+ cells 
in the Irf4–/– mice exhibiting a rounded morphology (Supple-
mental Figure 4A). By flow cytometry, Irf4–/– mice indeed had a 
reduced number of CD11b+ DCs in perinodal adipose tissue and 
associated LNs (Supplemental Figure 4, B and C). We followed 
up on these observations and generated Cd11c-Cre Irf4fl/fl mice, 
where deletion of Irf4 would occur in all DCs, most nonclassical 
monocytes, and in a minority of T and B cells (31). As in pre-
vious studies (31), we eliminated the occasional mouse whose 
blood lymphocytes indicated a greater than 25% deletion in 
the T or B cell compartment, as reported by the expression of 
GFP downstream of Irf4 gene deletion (32). As in the lung and 
intestine (31), the CD11b+ DC subset was reduced by more than 
half in perinodal adipose tissue around skin-draining LNs or 
mesenteric adipose tissue (Figure 6, A and B), but the CD24+ 
subset of DCs that also express CD103 and depend upon BATF3 
(33) was not reduced in the adipose tissue (Figure 6, A and B). 
In brachial LNs, total cellularity was normal (Figure 6C). Some 
subsets of the migratory DCs distinguished as a class by very 
high levels of MHC II (Figure 6D) were reduced in LNs, espe-
cially those that were CD11b+ (Figure 6E), but resident LN DCs 
were not significantly affected (Figure 6F). In mesenteric LNs, 
migratory DCs are recognized as CD103+CD11b+ (15, 34). These 
migratory DCs, as expected in Cd11c-Cre Irf4fl/fl mice (34), were 
significantly reduced in mesenteric LNs (Figure 6, G and H), 
but the resident LN DCs and overall LN cellularity remained 
close to normal (Figure 6, H and I).
Having established reduced perinodal DCs, along with 
lymph-migratory LN DCs, in Cd11c-Cre Irf4fl/fl mice, we next 
addressed whether the same lymphatic function parameters 
altered in Ccr7–/– mice were affected. Indeed, lymphatic collect-
ing vessel permeability was increased in lymphatic collecting 
vessels from the adipose tissue afferent to mesenteric or pop-
liteal LNs in Cd11c-Cre Irf4fl/fl mice to a degree similar to that 
in Ccr7–/– mice (Figure 7A). However, lymphatic transport of 
tracers injected into ear pinnae of Cd11c-Cre Irf4fl/fl mice was 
not significantly reduced (Figure 7B), leaving outcomes in this 
assay distinct from those in Ccr7–/– mice (Figure 4A) and mirror-
ing those of acute DC depletion in Cd11c-DTR mice (Figure 5, A 
and B). DC depletion in Cd11c-Cre Irf4fl/fl mice did not alter lym-
phatic capillary morphology significantly, whereas lymphatic 
capillaries were dilated in Ccr7–/– mice (Supplemental Figure 5), 
suggesting that defective lymphatic capillaries may account for 
the poor transport in Ccr7–/– mice that remains intact in Cd11c-
Cre Irf4fl/fl mice. Finally, the more chronic loss of DCs in the 
state of IRF4 deficiency, as compared with that in Cd11c-DTR 
mice with an acute loss of DCs, allowed us to observe accumu-
lation of collagen in the adventitial wall of collecting vessels in 
IRF4 deficiency (Figure 7C), thus supporting a strong relation-
ship between chronically elevated lymphatic permeability and 
fibrosis of lymphatic collecting vessels.
Discussion
The functionality of the lymphatic collecting vessel that has spon-
taneous contractile properties to promote lymph flow has not 
historically been a concern in immunology. However, recently, it 
has become clear that the permeability of the collecting vessels 
can affect the broadcast of antigen to APCs (14). Moreover, leak-
age or extreme elevations in permeability, at least in the intestine 
and mesenteric lymphatic network, have been associated with 
failure of the downstream LNs to receive input from DCs that 
normally enter LNs via the upstream lymphatic vasculature, lead-
ing to failed immunity and persistent inflammation (15). Through 
these observations, Fonseca de Morais et al. highlighted the need 
to better understand the mechanisms that regulate permeability 
in lymphatic collecting vessels, of which very little is presently 
known, in order to control inflammation and immunity. This body 
of work brings forward the chemokine receptor CCR7, expressed 
in some immune cells (DCs, T and B cells, innate lymphocytes), 
but no other known cell types, as a molecule that strongly affects 
lymphatic collecting vessel permeability.
Specifically, we found that genetic deletion of Ccr7 in mice 
elevates basal lymphatic collecting vessel permeability in mes-
enteric and skin-draining vessels by approximately 5-fold. This 
increase in permeability was observed in mice of all ages exam-
ined, including those as young as 5 weeks, the youngest age at 
which we could quantify collecting vessel permeability due to 
technical constraints. In addition to chronically elevated perme-
ability in Ccr7–/– mice, we observed collagen accumulation, appar-
ent fibrosis, around the collecting vessel adventitia starting at 7 
to 9 (Figure 2B) weeks of age, but not earlier. Based on previous 
literature, we propose that these fibrotic changes are an expected 
downstream consequence of persistently elevated flow across 
hyperpermeable vessels (21, 22). The inevitable onset of fibrotic 
changes, which were easily measured using 2-photon microscopy 
via measurement of the second harmonic signal, allowed us to 
extend our explorations on the role of the CCR7 beyond what we 
would be able to execute employing only the quite time-consum-
Figure 5. Evaluation of lymphatic permeability and transport in mice fol-
lowing acute DC depletion. (A) Cd11c-DTR and BDCA2-DTR mice were injected 
with DT at 4 ng/g of body weight; 36 hours after the administration of the 
toxin, the lymphatic collecting vessel was exteriorized and permeability was 
assessed (n = 9 mice per genotype, combined from 2 independent experi-
ments, mean ± SEM). (B) 1 μl of Cy5-conjugated dextran (70 kDa) was injected 
in the ear pinnae of anesthetized mice, and the decrease of fluorescence 
intensity associated with its transport from the initial site of deposition was 
assessed using a fluorescence stereoscope 36 hours after the administra-
tion of DT at 4 ng/g of body weight (n = 6 control and 6 Cd11c-DTR + DT mice 
combined from 2 independent experiments, mean ± SEM). For statistical 
evaluation, data were assessed using the Mann-Whitney U test. **P < 0.01.
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ing permeability assay. In particular, we measured elevated adven-
titial second harmonic signal in a second CCR7-deficient strain in 
which the human CCR7 gene was inserted in the mouse Ccr7 locus 
downstream of a floxed neo cassette (7). Cre recombinase–medi-
ated induction of CCR7 in DCs was sufficient to reverse the late-
stage fibrotic development around lymphatic collecting vessels. 
However, reexpression in CD4+ cells, mostly T cells, also strongly 
trended toward correction of the fibrotic phenotype, even though 
adventitial collagen was not increased in Rag2–/– mice entirely 
lacking T cells. It is thus possible that the role of CCR7 in affecting 
lymphatic collecting vessel functionality can be supplied by mul-
tiple CCR7+ cell types, but the role for DCs seems especially clear.
In addition, because intravital imaging data revealed that 
DCs actively interact with lymphatic collecting vessels, we car-
ried out further experiments to investigate the role of DCs in 
affecting lymphatic collecting vessel function. This analysis 
revealed that deletion of IRF4 selectively in CD11c+ cells reca-
pitulated the increased permeability, and ultimately fibrosis, in 
lymphatic collecting vessels that was observed in Ccr7–/– mice. 
Because IRF4 in DCs did not significantly reduce the presence 
of resident DCs in LNs, it is unlikely that resident LN DCs act as 
the regulators of collecting vessels. Instead, the data point to 2 
potential DC populations that were greatly decreased in Cd11c-
Cre Irf4fl/fl mice and are more likely culprits: (a) CD11b+ DCs that 
localize around collecting vessels, constitutively and intimately 
interacting with them, and (b) lymph-migratory DCs that home 
to LNs, which we confirmed, in agreement with the work of oth-
ers (34), are greatly decreased in Cd11c-Cre Irf4fl/fl mice. Unfortu-
nately, there are no additional genetic tools or other approaches 
available at present to further refine our analysis to distinguish 
which of these DC populations is most relevant to control of 
afferent collecting vessel permeability. It might seem most logi-
cal that the DCs that physically contact the collecting vessel 
regulate their permeability. Fitting with that hypothesis are our 
Figure 6. Analysis of DC subsets in perinodal adipose tissue and LNs of Cd11c-Cre Irf4fl/fl (Irf4ΔDC) mice and Irf4fl/fl controls. (A) Gating strategy used for 
identification of adipose tissue DC subsets, with mesenteric adipose tissue shown after pregating on CD45+CD64+ macrophages. DCs were identified as 
CD45+CD64–MHC II+CD11c+ (upper panel). Further, DCs were subdivided according to their cell-surface expression of the markers CD11b and CD24 (lower 
panel). (B) Enumeration of the DCs in the perinodal adipose tissue around brachial LNs (n = 3 for each genotype, mean ± SEM). (C) Cellularity of the bra-
chial LNs of control and Irf4ΔDC mice (n = 5 for each genotype, mean ± SEM). (D) Gating strategy used for identification of migratory (MHC IIhi) and resident 
DCs in the brachial LNs. Quantification of the populations of migratory (E) and resident (F) DCs in the brachial LNs (n = 5 for each genotype, mean ± SEM). 
(G) Gating strategy used for identification of DC subsets in the mesenteric LNs. DCs were pregated as MHC II+CD11c+ cells and then gated into 3 populations 
as shown, including CD11b+CD103+ cells, which are migratory DCs that fall between 2 resident DC subsets. (H) Quantification of the populations of DCs in 
the mesenteric LNs (n = 4–5 for each genotype, mean ± SEM). (I) Cellularity of the mesenteric LNs of control and Irf4ΔDC mice (n = 4–5 for each genotype, 
mean ± SEM). For statistical evaluation, data were assessed using the Mann-Whitney U test. *P < 0.05; **P < 0.01; ***P < 0.001. Ctrl, control.
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Bringing these concepts to pathophysiology, 
Fonseca de Morais et al. argued that dysfunc-
tionality in afferent lymphatic collecting vessels 
prevented migratory DCs from reaching mesen-
teric LNs, thus setting up a state of dysregulated 
immunity that, in the intestine, might promote 
processes associated with inflammatory bowel 
disease (15). However, if migratory DCs control 
the functionality of lymphatic collecting vessels, 
as described above, the relationship might be 
the other way around: circumstances that ablate 
DC migration through lymphatics alter both the 
function of LNs and upstream lymphatics. The 
potential connection of these concepts to inflam-
mation and disease makes this an important area 
for further future investigation.
Finally, while our live imaging experiments, 
specialized functional assays, and genetic analy-
ses link DCs to regulation of collecting vessel 
physiology, our studies on CCR7 point to roles in 
lymphatic function that may involve cells other 
than DCs. Not only do our data hint that CCR7 
expression on T cells may affect lymphatic col-
lecting homeostasis, but the removal of fluores-
cent tracers from the ear interstitium via lymphatic capillary 
vessels was impaired in Ccr7–/– mice, but not in mice with DC-
specific ablation of IRF4. When we then visualized the lym-
phatic capillaries in skin, only those in Ccr7–/– mice were dilated, 
consistent with fluid accumulation during impaired transport 
(38). Since both loss of IRF4 in DCs and CCR7 deficiency led to 
similarly altered lymphatic collecting vessel permeability, this 
transport defect in lymphatic capillaries of Ccr7–/– mice is likely 
unrelated to altered lymphatic permeability. In short, this work 
identifies roles for CCR7 in controlling lymphatic vessel trans-
port and function, and a major player, though perhaps not alone, 
in this regulation is the IRF4+ DC. This insight will be useful in 
further dissecting the underlying pathophysiology following Y. 
pestis infection and beyond.
Methods
Animals. Cx3cr1gfp/gfp mice and C57BL/6 WT mice were purchased from 
The Jackson Laboratory. Ccr7–/– mice (5) were purchased from The 
Jackson Laboratory and maintained at Washington University School 
of Medicine or bred and maintained at Hannover Medical School 
along with Ccr7–/–CCR7stop/stop mice crossed or not to Cd11c-Cre or CD4-
Cre mice (7). Ccr7–/– mice were interbred with Cd11c-YFP reporter mice 
(16). Cd11c-DTR transgenic mice, also purchased from The Jackson 
Laboratory, have been described (25), as have BDCA2-DTR mice bred 
and maintained at Washington University (26). Prox1-ERT2-Cre mice 
(17) were a gift from Guillermo Oliver (Northwestern University, Chi-
cago, Illinois, USA) and were bred to Rosa26S or floxed-stop tdTomato 
(fstdT) reporter mice (The Jackson Laboratory, JAX stock number 
007905). Resulting Prox1-ERT2-Cre Tomato reporter mice were uti-
lized for imaging or further crossed to Ccr7–/– CD11c-YFP reporter mice 
described above. Irf4–/– mice (39) were bred and maintained at Wash-
ington University and provided for these studies by Ken Murphy of 
that institution. Irf4ΔDC mice were generated at Washington University 
data showing that isolated vessels, bearing no direct connection 
to LNs when prepared ex vivo, still show a DC-dependent shift 
in permeability. However, what key signals are provided by DC-
lymphatic interactions on the collecting vessel route through adi-
pose tissue remain unclear. CD11b+ DCs isolated from adipose 
tissue do show selective expression of extracellular matrix com-
ponents such as fibronectin and proteases such as PAI-1 (http://
www.immgen.org) that in other areas of vascular biology strong-
ly affect vessel function. Future studies are needed to evaluate 
the role of these and other adipose DC–selective molecules in 
the regulation of lymphatic collecting vessel permeability.
It is also reasonable to consider that lymph-migratory DCs 
that pass through collecting vessels on their way to LNs con-
trol lymphatic collecting vessel function, although how they 
would do so in assays that utilize isolated vessels lacking LNs 
is unclear. Such lymph-migratory DCs, exquisitely dependent 
upon CCR7 for their trafficking to LNs, are known to regulate 
the maturation of the specialized postcapillary venules in LNs, 
the HEVs (3, 4, 7). From this perspective, it is interesting to note 
that classical studies on lymphatic collecting vessels in dogs, 
done in vivo with LNs remaining functional during collecting 
vessel cannulations, show a key role for LN venules in fluid 
exchange and lymph flow (35–37). Specifically, the venules in 
LNs are responsible for uptake of water during the appreciable 
concentration of afferent lymph before it traverses the LN and 
enters efferent lymph (35). High pressure in the efferent lym-
phatic collecting vessels was able to drive afferent lymphatic 
vessel leakiness due to venous collapse in the LNs (37). Thus, a 
role for migratory DCs in controlling the maturation state and 
overall functionality of the HEVs may indeed influence the per-
meability of the afferent lymphatic collecting vessels that we 
have studied here, perhaps even after these vessels have been 
isolated and separated from LNs.
Figure 7. Analysis of the role of IRF4-dependent DCs in lymphatic transport and perme-
ability. (A) Measurement of lymphatic collecting vessel permeability taken from mesenteric 
and popliteal adipose tissue of control (Ctrl; Irf4fl/fl) and Irf4ΔDC (CD11c-Cre Irf4fl/fl) mice (n = 4–5 
mice per genotype, mean ± SEM). (B) 1 μl of Cy5-conjugated dextran (70 kDa) was injected in 
the ear pinnae of anesthetized mice, and the decrease of fluorescence intensity associated 
with its transport from the initial site of deposition was assessed using a fluorescence ste-
reoscope (n = 7 mice per genotype, mean ± SEM). (C) 2-Photon intravital analysis of adven-
titial wall thickness, assessed through measurement of second harmonic signal, around 
lymphatic collecting vessels in control and Irf4-deficient mice (Irf4–/– or Cd11c-Cre Irf4fl/fl). 
Eight mice per genotype were examined at multiple areas along the lymphatic collecting ves-
sels, with multiple videos made in different areas per mouse. Each data point represents the 
mean of 1 mouse after blind scoring of 6 to 12 Z-stacks per mouse. For statistical evaluation, 
data in A and B were assessed using the Mann-Whitney U test. **P < 0.01; ***P < 0.001. 
Data in C were assessed using 1-way ANOVA, Tukey’s post hoc test.
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3D stacks consisting of between 21 and 31 planes (2.5 μm step size) 
were captured every 30 seconds.
Alternatively, for 2-photon imaging at Hannover Medical 
School, the following microscope setup was used: TriM Scope (LaVi-
sion Biotec), Olympus BX51 upright microscope, ×20/0.95 water 
immersion objective (Olympus), and MaiTai Ti:Sa pulsed infrared 
laser (Spectra-Physics) at 865 nm. For separation, this system used 
longpass filters at 485, 550, and 600 nm and additional bandpass 
filters of 447/60 and 624/40. Z-stacks were acquired over a total of 
31 to 71 planes (2-μm step size).
2-Photon excitation produced a second harmonic signal from col-
lagen within the analyzed tissue (40). Multidimensional rendering and 
manual cell tracking was done with Imaris (Bitplane). Mean track veloc-
ities (μm/min) and motility coefficients (μm2/min) were calculated for 
individual tracks spanning 11 time points (or 5 minutes) (41). The motil-
ity coefficient was defined as the slope of the fitted line of displacement 
squared versus time. The meandering factor was calculated by dividing 
the displacement of a cell by its total path length. All track calculations 
were performed using T cell Analyser version 1.7.0 software (http://spi-
der.science.strath.ac.uk/sipbs/showPage.php?page=software_imag-
ing), written by J. Dempster (University of Strathclyde, Glasgow, Scot-
land) (40). Data were transferred and plotted in GraphPad Prism 6 
(GraphPad Software Inc.) for creation of the graphs.
Electron microscopy. WT and Ccr7–/– mice were euthanized and 
immediately perfused with 4% paraformaldehyde and 2.5% glutaral-
dehyde in PBS. Anterior s.c. fat containing brachial LNs was excised 
and cut in the midsection with respect to the region containing the 
afferent lymphatic vessel (14), and blocks were prepared and pro-
cessed for standard transmission electron microscopy by the Univer-
sity of Virginia Advanced Microscopy and Histology Core. Sections 
were evaluated using a Joel 1220 electron microscope.
Analysis of adventitial wall diameter and luminal diameter of lym-
phatic collecting vessel. Single 2-photon–generated videos were ana-
lyzed at Washington University School of Medicine and Hannover 
Medical School by individuals blinded to the genotype and age of 
the mice used to generate the data. For analysis, multiple Z-stacks 
per mouse were examined in the middle region (along the z axis) 
of the vessel, and the thickness of the lymphatic collector wall and 
the diameter of the lumen of the collector vessel were quantified 
using Imaris software. Further, the ratio between the lymphatic 
lumen diameter and the lymphatic wall diameter was calculated. 
After data were unblinded, graphical depictions of the results were 
prepared using GraphPad Prism 6.
Estimation of surface area of contact between lymphatic vessel and 
DCs. Surfaces of the lymphatic vessel and DCs were created using 
the surface function in Imaris. The surfaces were then imported into 
MATLAB as X, Y, and Z Cartesian coordinates. To determine the con-
tact between the vessel and the cell, a threshold was predetermined 
(1 micron), and the distance between each vessel and cell Cartesian 
coordinate was calculated using the Euclidean distance formula 
(Equation 1). The points of the vessel that were within the distance 
threshold were then used to estimate the surface area, as these were 
the points considered to be in contact with a cell. The subset of vessel 
points was then projected onto the plane of most variance, found using 
singular value decomposition (Equation 2). The surface area was esti-
mated from this 2D object by finding its convex hull and then calculat-
ing the area of the convex hull using MATLAB.
by breeding B6.129S1-Irf4tm1Rdf/J (Irf4fl/fl) mice with B6.Cg-Tg(Itgax–
Cre)1-1Reiz/J (Itgax–Cre) mice (both strains from The Jackson Labora-
tory). This strain was exported, maintained, and additionally studied 
at the INSERM UMRS 1166 (Paris, France).
Immunostaining and whole-mount imaging. Tissues were fixed over-
night in 4% PFA containing 30% sucrose. Tissues were then incubated 
in 1% chicken OVA plus 0.015% Triton X-100 for 2 hours or more, 
depending on the size of the tissue, and then transferred to PBS con-
taining 0.2% OVA and primary Abs overnight at 4°C. Immunostaining 
was carried out using anti–MHC II (eBioscience, clone M5/14.15.2), 
anti-CCL21 (R&D Systems, clone 59106), or anti-podoplanin Ab (pur-
chased from AngioBio). Three washes were carried out in PBS, at 10 
minutes each, and then secondary, conjugated Abs were added at 4°C 
overnight. Secondary Abs used for detection of these Abs were Cy3-
conjugated anti-rat Ab, Cy5-conjugated anti-rabbit Ab, and Cy5-con-
jugated anti–Syrian hamster Ab (both from Jackson Immunoresearch). 
Nuclear contrast was provided by the addition of DAPI. Washed tissues 
were then dehydrated in a series of alcohol dilutions that started with 
70% ethanol and culminated in 100% ethanol. Then tissue was trans-
ferred into methyl salicylate to achieve optical clarification that permit-
ted optimal confocal imaging. Images were acquired on a Leica SPE 
confocal microscope equipped with a tile-scanning feature.
Flow cytometry. Single-cell adipose tissue suspensions were 
obtained from minced adipose tissue subjected to collagenase D (3 
mg/ml) (Roche) digestion for 45 minutes at 37°C and then treated with 
red blood cells lysis buffer (BD Biosciences). Cells were stained with 
combinations of the following mAbs for 25 minutes on ice, protected 
from light. mAbs included those directed against CD45 V500–con-
jugated Abs (BD Horizon, clone 30-F11) or Pacific Blue–conjugated 
Abs (BioLegend, clone 30-F11), CD11c Pe-Cy7–conjugated Abs (Bio-
Legend, clone N418), CD11b APC-Cy7–conjugated Abs (Biolegend, 
clone M1/70), CD24 PerCP-Cy5.5–conjugated Abs (BD Biosciences 
— Pharmingen, clone M1/69), CD64 APC–conjugated Abs (BD Biosci-
ences — Pharmingen, clone X54-5/7.1), F4/80 APC-Cy7–conjugated 
Abs (BioLegend, clone CI:A3-1), and MHC II eFluor450– or FITC-con-
jugated Abs (eBioscience, clone M5/14.15.2). Abs to MerTK (BAF 591) 
were from R&D Systems and were used in combination with strepta-
vidin PerCP-Cy5.5–conjugated Abs (BioLegend). Cells were analyzed 
on the LSR Fortessa (BD) instrument equipped with DIVA software. 
Samples were later analyzed using FlowJo software (Tree Star).
2-Photon microscopy. Mice were anesthetized by i.p. injection of 
ketamine (50 mg/kg) and xylazine (10 mg/kg) and maintained with 
halved doses administered every hour. Mice analyzed at Hannover 
Medical School received 1 i.p. injection of ketamine (100 mg/kg) and 
medetomidine (1 mg/kg). Mouse legs were carefully shaved with Nair 
(Church & Dwight Co.) and washed with 1× PBS to remove the extra 
lotion. The superficial layer of the skin was removed, and the lym-
phatic collecting vessels in the popliteal region were visualized via 
s.c. injection of 10 to 20 μl of DyLight 594–conjugated tomato lectin 
(Vector Laboratories) into the footpad. During the acquisition, mouse 
status was closely monitored.
Images were collected at Washington University using a custom-
ized Leica SP8 2-photon microscope equipped with a ×25/0.95 NA 
water-dipping objective and a Mai Tai HP DeepSee Laser (Spectra-
Physics) tuned to 900 nm. Fluorescence emission was separated by 
3 high-efficiency dichroic mirrors cutting at 458, 495, and 560 nm 
(Semrock) and directly directed to 4 supersensitive external detectors. 
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from the mouse mesentery so that adipose and connective tissues 
could be carefully removed. These isolated collecting lymphatics 
were then tied onto glass micropipettes to enable perfusion with 
solutions containing a fluorescent-tagged albumin or containing 
an unlabeled albumin. Fluorescence intensity was measured over 
a rectangular region of interest that sampled light from the vessel 
lumen and adjacent buffer. All vessels were perfused at a constant, 
low pressure and flow (<10 cm H2O). Upon perfusing the fluores-
cent albumin, a rapid, step increase in fluorescence intensity (Io) 
was recorded on the photometer. Over time, the fluorescent albu-
min moved across the lymphatic vessel wall into the surrounding 
bath solution, which caused a gradual but linear increase in pho-
tometer voltage (dIf/dt). Afterwards, perfusion of the unlabeled 
albumin washed away all fluorescence, returning the photometer 
voltage to baseline, and allowed repeated measurements to be 
made. Albumin permeability (Ps, cm/s) was calculated from a modi-
fied form of Fick’s first law, which relates albumin flux to a constant 
(i.e., unchanging) surface area (S, cm2) and concentration gradient 
(ΔC, mmol/ml): Ps = Js/SΔC = (1/Io)(dIf/dt)(D/4), where collecting 
lymphatic diameter (D, cm) was simultaneously measured on a 
computer monitor to ensure that it did not change for the duration 
of each recording.
Statistics. The statistical significance of differences in mean val-
ues was analyzed with Mann-Whitney U test or ANOVA for multiple 
comparisons, then by Tukey’s post hoc test. P < 0.05 was considered 
statistically significant. Errors shown in bar graphs and mentioned in 
text refer to ± SEM.
Study approval. All experimental procedures were approved by the 
animal studies committees of Washington University School of Medi-
cine, the Department of Medical Pharmacology and Physiology, Uni-
versity of Missouri, Mount Sinai School of Medicine, Hannover Medi-
cal School, or Paris VI University.
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     (Equation 1)
 
     (Equation 2)
where d(c, v) is the distance between points c and v; c = (c1, c2, c3) is a 
point of a cell; v = (v1, v2, v3) is a point of a vessel; M is an m × 3 matrix 
of the coordinates of the vessel that are in contact with a cell (or points 
in contact); U is an m × m orthogonal matrix where m is the number of 
points in contact; Σ is a m × 3 diagonal matrix with the singular values 
on the diagonal; V is a 3 × 3 orthogonal matrix; and V* is the conjugate 
transpose of the nSn orthogonal matrix V.
Lymphatic capillary staining and function analysis. Ears were split 
along the dorsal-ventral axis and fixed in 4% paraformaldehyde. Dor-
sal preparations were stained with goat anti-mouse LYVE-1 Ab (R&D 
Systems) followed by Cy3-labeled secondary Ab or, if from Prox1 
reporter mice, visualized directly. Low-magnification images of the 
lymphatic capillaries near the ear edges were made using a Leica SPE 
confocal microscope and lymphatic diameter, and branch point den-
sity was assessed using Imaris software.
For transport analysis, as previously described (19), the hair from 
ears was removed 1 day before the experiment. A total of 1 μl Cy5-
conjugated dextran (70 kDa; Nanocs) at a concentration of 2 mg/ml 
in sterile PBS was injected via a Hamilton syringe intradermally (i.d.) 
into the ear. Fluorescence was observed through skin using a fluores-
cence stereomicroscope (M205FA Leica), and images of the skin were 
acquired each minute for 15 minutes using constant exposure time. 
Fluorescence intensity and exposure times were adjusted to ensure 
that intensity values were linearly proportional to the actual fluores-
cence. Images were processed using ImageJ (http://imagej.nih.gov/
ij/) and FiJi software (http://fiji.sc/Fiji), and the rate of clearance was 
determined by first calculating the area under the curve of fluores-
cence intensity in the injection region at each time point, normalized 
to the initial value. The normalized rate of fluorescence decay was 
then calculated from the slope of area under the curve versus time. 
This was considered proportional to the actual rate of Cy5-dextran 
clearance. Left and right assessments were made at each ear in each 
mouse, and the 2 normalized values were averaged to generate 1 mean 
value per mouse per site.
Vessel isolation and cannulation. Mice were anesthetized with pen-
tobarbital sodium (Nembutal, 60 mg/kg, i.p.), and the intestines were 
exposed through a 2- to 3-cm midline incision. Lymphatic collecting 
vessels in the mesentery were isolated under a stereomicroscope and 
placed in Krebs buffer containing 0.5% BSA. Adipose tissue was careful-
ly removed from isolated lymphatics in a Sylgard-coated chamber. The 
lymphatic collecting vessels were tied onto 2 glass micro pipettes (~80 
μm OD each) submerged in Krebs buffer in a chamber with a water jack-
et for temperature control. The perfusion micropipette had 2 lumens; 
thus, it was capable of perfusing either unlabeled or fluorescently 
tagged BSA. After cannulation, the vessel was warmed to 37°C over 45 
minutes on a Zeiss Axiovert 100TV inverted fluorescence microscope.
Lymphatic solute permeability assay. As previously described 
(13, 42), albumin flux (Js, mmol/s) across the lymphatic collecting 
vessel wall was measured directly with microscope-based photom-
etry. Briefly, lymphatic collecting vessels were surgically excised 
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